Related Experiment Video
Updated: Aug 27, 2025

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
568
Regarding "Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients
Hiroshi Imamura1, Kiyoshi Hasegawa2, Yuji Soejima2,3
1Department of Hepatobiliary-Pancreatic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Liver Cancer
|September 26, 2022
Abstract
No abstract available in PubMed .

